Sale!

ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ACTA2 gene plays a crucial role in the smooth muscle cells that line the aorta, which is the largest artery in the body responsible for carrying blood from the heart to the rest of the body. Mutations in the ACTA2 gene can lead to a condition known as Aortic Aneurysm, Familial Thoracic Type 6. This genetic disorder is characterized by the weakening and abnormal dilation of the aortic wall, which can lead to life-threatening events such as aortic dissection or rupture if not properly managed.

To diagnose this condition and identify individuals at risk, a specific genetic test is available at DNA Labs UAE. This test specifically looks for mutations in the ACTA2 gene that are known to contribute to the development of Aortic Aneurysm, Familial Thoracic Type 6. By identifying these mutations, healthcare providers can better understand an individual’s risk for developing this condition and can implement appropriate monitoring and management strategies to prevent serious complications.

The cost of the ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals with a family history of thoracic aortic aneurysms, as it provides critical information that can guide clinical decisions and potentially life-saving interventions.

Description

ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test

Test Name: ACTA2 Gene Aortic Aneurysm Familial Thoracic Type 6 Genetic Test

Components: ACTA2 gene analysis

Price: 4400.0 AED

Sample Condition: Blood

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Vascular Diseases

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ACTA2 Gene Aortic Aneurysm, Familial Thoracic Type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA2 Gene Aortic Aneurysm, Familial Thoracic Type 6 NGS Genetic DNA Test gene ACTA2

Test Details:

The ACTA2 gene is associated with a condition called familial thoracic aortic aneurysm, type 6 (FTAAD6). This condition is characterized by the weakening and dilation of the aorta, the main blood vessel that carries oxygenated blood from the heart to the rest of the body. FTAAD6 is an inherited disorder, meaning it can be passed down through families.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the ACTA2 gene. This test can identify mutations or variations in the ACTA2 gene that may be associated with familial thoracic aortic aneurysm type 6. By identifying these genetic changes, NGS testing can help diagnose individuals with FTAAD6 and provide information about their risk of developing aortic aneurysms. It can also be used for genetic counseling and to inform family members about their risk of inheriting the condition.

It’s important to note that a genetic test alone may not be sufficient to diagnose FTAAD6, as other factors such as medical history, physical examination, and imaging tests may also be necessary. Therefore, it is recommended to consult with a healthcare professional or a genetic counselor for a comprehensive evaluation and guidance on genetic testing.

Test Name	ACTA2 Gene Aortic aneurysm familial thoracic type 6 Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Vascular Diseases
Doctor	General Physician
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for ACTA2 Gene Aortic aneurysm, familial thoracic type 6 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ACTA2 Gene Aortic aneurysm, familial thoracic type 6 NGS Genetic DNA Test gene ACTA2
Test Details	The ACTA2 gene is associated with a condition called familial thoracic aortic aneurysm, type 6 (FTAAD6). This condition is characterized by the weakening and dilation of the aorta, the main blood vessel that carries oxygenated blood from the heart to the rest of the body. FTAAD6 is an inherited disorder, meaning it can be passed down through families. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that allows for the simultaneous analysis of multiple genes, including the ACTA2 gene. This test can identify mutations or variations in the ACTA2 gene that may be associated with familial thoracic aortic aneurysm type 6. By identifying these genetic changes, NGS testing can help diagnose individuals with FTAAD6 and provide information about their risk of developing aortic aneurysms. It can also be used for genetic counseling and to inform family members about their risk of inheriting the condition. It’s important to note that a genetic test alone may not be sufficient to diagnose FTAAD6, as other factors such as medical history, physical examination, and imaging tests may also be necessary. Therefore, it is recommended to consult with a healthcare professional or a genetic counselor for a comprehensive evaluation and guidance on genetic testing.